[$$] Last Week
moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to view […]
AGN
Exclusive – Allergan approached Shire about takeover but rebuffed: sources
moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to view […]
[$$] Allergan Can Turn Guns on Valeant
[at The Wall Street Journal] – Valeant’s hostile offer for Allergan, backed by Bill Ackman, will be hard to resist, but it will likely take a higher price to get done. moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to view […]
[$$] Flurry of Allergan Trading Preceded Offer
[at The Wall Street Journal] – Investors made outsize bets on Allergan stock in the 10 days during which activist hedge-fund manager William Ackman was privately accumulating a stake in the Botox maker, according to a Wall Street Journal … moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is […]
[$$] Allergan Pursuer Valeant: A Drug Maker With Little Patience for Science
[at The Wall Street Journal] – Allergan spends 17% of its revenue on R&D. Michael Pearson has cut Valeant’s spending to 3%, setting up a culture clash as he attempts to purchase the Botox maker. moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to […]
Allergan stock climbs amid $46-billion bid
moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to view […]
ALLERGAN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Allergan, Inc.
[PR Newswire] – NEW ORLEANS, April 22, 2014 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale … moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click […]
[$$] Flurry of Allergan Trading Preceded Offer
[at The Wall Street Journal] – Investors made outsize bets on Allergan stock in the 10 days during which activist hedge-fund manager William Ackman was privately accumulating a stake in the Botox maker, according to a Wall Street Journal … moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is […]
[$$] Allergan Pursuer Valeant: A Drug Maker With Little Patience for Science
[at The Wall Street Journal] – Allergan spends 17% of its revenue on R&D. Michael Pearson has cut Valeant’s spending to 3%, setting up a culture clash as he attempts to purchase the Botox maker. moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to […]
Allergan Adopts One-Year Stockholder Rights Plan
[Business Wire] – Allergan, Inc. today announced that its Board of Directors has unanimously adopted a one-year stockholder rights plan (the “ moreView todays social media effects on AGNView the latest stocks trending across Twitter. Click to view dashboardSee who Allergan is hiring next, click here to view […]
